Kyndryl Faces Expanded Securities Class Action
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy KD?
Source: Globenewswire
- Litigation Expansion: Hagens Berman has filed an expanded securities class action against Kyndryl Holdings, Inc., aiming to represent all investors who purchased Kyndryl securities between August 1, 2024, and February 6, 2026, thereby broadening the scope of affected investors and raising serious concerns about the company's financial transparency.
- Cash Flow Manipulation Allegations: The lawsuit alleges that Kyndryl's reported free cash flow was artificially inflated by undisclosed and unsustainable cash management practices, leading to a misunderstanding of the company's financial health among investors, which could adversely affect investor confidence and market performance.
- Stock Price Collapse: Following the February 9, 2026 announcement of an SEC investigation and executive departures, Kyndryl's stock plummeted by 55%, dropping from $23.49 to $10.59, indicating extreme market concern over the company's financial condition and potentially resulting in significant investor losses.
- Leadership Changes: Kyndryl announced the immediate departure of its CFO and General Counsel alongside the SEC investigation disclosure, further exacerbating market unease and severely undermining investor confidence in the company's future prospects.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy KD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on KD
Wall Street analysts forecast KD stock price to rise
4 Analyst Rating
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 12.360
Low
28.00
Averages
33.25
High
40.00
Current: 12.360
Low
28.00
Averages
33.25
High
40.00
About KD
Kyndryl Holdings, Inc. is a provider of mission-critical enterprise technology services offering advisory, implementation and managed service capabilities to customers in more than 60 countries. The Company designs, builds, manages and modernizes complex information systems around the world. Its segments include United States, Japan, Principal Markets and Strategic Markets. It offers services across domains, such as cloud services, core enterprise and zCloud services, applications, data and artificial intelligence (AI) services, digital workplace services, security and resiliency services and network and edge services. Its advisory and implementation services are branded as Kyndryl Consult. It provides end-to-end enterprise data services, including data transformation, data architecture and management, data governance and compliance and data migration. It provides comprehensive enterprise cybersecurity services for chief information security officers (CISOs) and chief risk officers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Kyndryl Faces Expanded Securities Class Action
- Litigation Expansion: Hagens Berman has filed an expanded securities class action against Kyndryl Holdings, Inc., aiming to represent all investors who purchased Kyndryl securities between August 1, 2024, and February 6, 2026, thereby broadening the scope of affected investors and raising serious concerns about the company's financial transparency.
- Cash Flow Manipulation Allegations: The lawsuit alleges that Kyndryl's reported free cash flow was artificially inflated by undisclosed and unsustainable cash management practices, leading to a misunderstanding of the company's financial health among investors, which could adversely affect investor confidence and market performance.
- Stock Price Collapse: Following the February 9, 2026 announcement of an SEC investigation and executive departures, Kyndryl's stock plummeted by 55%, dropping from $23.49 to $10.59, indicating extreme market concern over the company's financial condition and potentially resulting in significant investor losses.
- Leadership Changes: Kyndryl announced the immediate departure of its CFO and General Counsel alongside the SEC investigation disclosure, further exacerbating market unease and severely undermining investor confidence in the company's future prospects.
See More
Kyndryl Holdings Faces Securities Fraud Class Action Lawsuit
- Lawsuit Background: Kyndryl Holdings, Inc. (NYSE: KD) is facing a class action lawsuit for securities fraud, alleging significant misstatements regarding its financial reporting and cash management practices during the period from August 1, 2024, to February 9, 2026, which could lead to substantial investor losses.
- Stock Price Plunge: Following the announcement of its Q1 2026 financial results on August 4, 2025, Kyndryl missed analysts' revenue and free cash flow estimates, resulting in a $7.76 drop in stock price, over 21.1%, indicating market concerns about its financial stability.
- Executive Departures Impact: On February 9, 2026, Kyndryl unexpectedly announced the immediate departure of its CFO and General Counsel, revealing an ongoing review of its cash management disclosures and internal controls, which led to a staggering 54% drop in stock price within days.
- Investor Action Recommendations: Affected investors are encouraged to apply for lead plaintiff status by April 13, 2026, to represent other investors in the class action, underscoring the importance of corporate governance and financial transparency in protecting shareholder interests.
See More
Kyndryl Faces Class Action Securities Lawsuits
- Lawsuit Notification: Kahn Swick & Foti LLC has notified Kyndryl investors of class action securities lawsuits aimed at recovering losses for those affected by alleged securities fraud between August 2024 and February 2026.
- Financial Reporting Delay: On February 9, 2026, Kyndryl disclosed its inability to timely file its Form 10-Q for the quarter ended December 31, 2025, anticipating material weaknesses in internal controls that could impact financial transparency.
- Stock Price Plunge: Following this announcement, Kyndryl's stock price plummeted by 55%, dropping $12.90 to close at $10.59, indicating severe market concerns regarding the company's financial health.
- Investor Action: Affected investors have until April 13, 2026, to request appointment as lead plaintiff in the lawsuit, although sharing in any recovery does not require serving as lead plaintiff.
See More
Kyndryl Securities Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Kyndryl securities between August 7, 2024, and February 9, 2026, to apply as lead plaintiffs by April 13, 2026, to potentially receive compensation without any out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that Kyndryl made materially false statements during the class period, lacked adequate internal controls, and failed to timely file its Quarterly Report for the quarter ended December 31, 2025, resulting in investor losses.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest settlement against a Chinese company, ranked No. 1 by ISS Securities Class Action Services in 2017, highlighting its expertise and success in this field.
- Investor Guidance: Investors are advised to select qualified counsel with a proven track record, avoiding firms that merely act as intermediaries, to ensure they receive the best representation and support in the class action.
See More
Kyndryl Accused of Concealing Cash Flow Metrics
- Litigation Expansion: Hagens Berman has expanded its securities class action against Kyndryl Holdings, Inc., now covering investors from August 1, 2024, to February 6, 2026, alleging concealment of true cash flow metrics that led to a 55% stock collapse.
- Financial Health Concerns: The new lawsuit claims that Kyndryl's reported free cash flow was based on undisclosed and unsustainable cash management practices, masking the company's actual financial condition and undermining investor confidence.
- Impact of Executive Departures: Following the abrupt departure of the CFO and General Counsel, the public revelation of an SEC investigation resulted in significant market value loss, severely impacting investor trust in Kyndryl's future.
- Whistleblower Program: Hagens Berman encourages individuals with non-public information to utilize the SEC Whistleblower program, offering rewards of up to 30% of any successful recovery, which could further expose Kyndryl's financial issues.
See More
Multiple Companies Facing Class Action Lawsuits
- Oracle Lawsuit: Oracle Corporation faces a class action lawsuit for the period from June 12 to December 16, 2025, due to its AI infrastructure strategy leading to significant CapEx increases, which poses serious risks to its debt and credit rating, potentially affecting its ability to fund projects.
- Paysafe Issues: Paysafe Limited is being sued for the period from March 4 to November 12, 2025, for failing to disclose significant exposure to a single high-risk client, resulting in understated credit loss reserves that could negatively impact revenue growth.
- Inovio Pharmaceuticals Litigation: Inovio Pharmaceuticals, during the period from October 10, 2023, to December 26, 2025, faces a lawsuit alleging deficiencies in manufacturing its CELLECTRA device, which may hinder its ability to submit the INO-3107 BLA to the FDA on time, affecting regulatory and commercial prospects.
- Kyndryl Financial Misstatements: Kyndryl Holdings is under litigation for the period from August 1, 2024, to February 9, 2026, due to materially misstated financial statements and inadequate internal controls, which may prevent timely filing of its quarterly report, impacting investor confidence and company reputation.
See More
Kyndryl Faces Expanded Securities Class Action
- Litigation Expansion: Hagens Berman has filed an expanded securities class action against Kyndryl Holdings, Inc., aiming to represent all investors who purchased Kyndryl securities between August 1, 2024, and February 6, 2026, thereby broadening the scope of affected investors and raising serious concerns about the company's financial transparency.
- Cash Flow Manipulation Allegations: The lawsuit alleges that Kyndryl's reported free cash flow was artificially inflated by undisclosed and unsustainable cash management practices, leading to a misunderstanding of the company's financial health among investors, which could adversely affect investor confidence and market performance.
- Stock Price Collapse: Following the February 9, 2026 announcement of an SEC investigation and executive departures, Kyndryl's stock plummeted by 55%, dropping from $23.49 to $10.59, indicating extreme market concern over the company's financial condition and potentially resulting in significant investor losses.
- Leadership Changes: Kyndryl announced the immediate departure of its CFO and General Counsel alongside the SEC investigation disclosure, further exacerbating market unease and severely undermining investor confidence in the company's future prospects.
See More
Kyndryl Holdings Faces Securities Fraud Class Action Lawsuit
- Lawsuit Background: Kyndryl Holdings, Inc. (NYSE: KD) is facing a class action lawsuit for securities fraud, alleging significant misstatements regarding its financial reporting and cash management practices during the period from August 1, 2024, to February 9, 2026, which could lead to substantial investor losses.
- Stock Price Plunge: Following the announcement of its Q1 2026 financial results on August 4, 2025, Kyndryl missed analysts' revenue and free cash flow estimates, resulting in a $7.76 drop in stock price, over 21.1%, indicating market concerns about its financial stability.
- Executive Departures Impact: On February 9, 2026, Kyndryl unexpectedly announced the immediate departure of its CFO and General Counsel, revealing an ongoing review of its cash management disclosures and internal controls, which led to a staggering 54% drop in stock price within days.
- Investor Action Recommendations: Affected investors are encouraged to apply for lead plaintiff status by April 13, 2026, to represent other investors in the class action, underscoring the importance of corporate governance and financial transparency in protecting shareholder interests.
See More
Kyndryl Faces Class Action Securities Lawsuits
- Lawsuit Notification: Kahn Swick & Foti LLC has notified Kyndryl investors of class action securities lawsuits aimed at recovering losses for those affected by alleged securities fraud between August 2024 and February 2026.
- Financial Reporting Delay: On February 9, 2026, Kyndryl disclosed its inability to timely file its Form 10-Q for the quarter ended December 31, 2025, anticipating material weaknesses in internal controls that could impact financial transparency.
- Stock Price Plunge: Following this announcement, Kyndryl's stock price plummeted by 55%, dropping $12.90 to close at $10.59, indicating severe market concerns regarding the company's financial health.
- Investor Action: Affected investors have until April 13, 2026, to request appointment as lead plaintiff in the lawsuit, although sharing in any recovery does not require serving as lead plaintiff.
See More
Kyndryl Securities Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Kyndryl securities between August 7, 2024, and February 9, 2026, to apply as lead plaintiffs by April 13, 2026, to potentially receive compensation without any out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that Kyndryl made materially false statements during the class period, lacked adequate internal controls, and failed to timely file its Quarterly Report for the quarter ended December 31, 2025, resulting in investor losses.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest settlement against a Chinese company, ranked No. 1 by ISS Securities Class Action Services in 2017, highlighting its expertise and success in this field.
- Investor Guidance: Investors are advised to select qualified counsel with a proven track record, avoiding firms that merely act as intermediaries, to ensure they receive the best representation and support in the class action.
See More
Kyndryl Accused of Concealing Cash Flow Metrics
- Litigation Expansion: Hagens Berman has expanded its securities class action against Kyndryl Holdings, Inc., now covering investors from August 1, 2024, to February 6, 2026, alleging concealment of true cash flow metrics that led to a 55% stock collapse.
- Financial Health Concerns: The new lawsuit claims that Kyndryl's reported free cash flow was based on undisclosed and unsustainable cash management practices, masking the company's actual financial condition and undermining investor confidence.
- Impact of Executive Departures: Following the abrupt departure of the CFO and General Counsel, the public revelation of an SEC investigation resulted in significant market value loss, severely impacting investor trust in Kyndryl's future.
- Whistleblower Program: Hagens Berman encourages individuals with non-public information to utilize the SEC Whistleblower program, offering rewards of up to 30% of any successful recovery, which could further expose Kyndryl's financial issues.
See More
Multiple Companies Facing Class Action Lawsuits
- Oracle Lawsuit: Oracle Corporation faces a class action lawsuit for the period from June 12 to December 16, 2025, due to its AI infrastructure strategy leading to significant CapEx increases, which poses serious risks to its debt and credit rating, potentially affecting its ability to fund projects.
- Paysafe Issues: Paysafe Limited is being sued for the period from March 4 to November 12, 2025, for failing to disclose significant exposure to a single high-risk client, resulting in understated credit loss reserves that could negatively impact revenue growth.
- Inovio Pharmaceuticals Litigation: Inovio Pharmaceuticals, during the period from October 10, 2023, to December 26, 2025, faces a lawsuit alleging deficiencies in manufacturing its CELLECTRA device, which may hinder its ability to submit the INO-3107 BLA to the FDA on time, affecting regulatory and commercial prospects.
- Kyndryl Financial Misstatements: Kyndryl Holdings is under litigation for the period from August 1, 2024, to February 9, 2026, due to materially misstated financial statements and inadequate internal controls, which may prevent timely filing of its quarterly report, impacting investor confidence and company reputation.
See More
